173.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$172.07
Offen:
$171.14
24-Stunden-Volumen:
567.86K
Relative Volume:
0.87
Marktkapitalisierung:
$15.22B
Einnahmen:
$12.67B
Nettoeinkommen (Verlust:
$827.68M
KGV:
18.72
EPS:
9.27
Netto-Cashflow:
$1.42B
1W Leistung:
-1.49%
1M Leistung:
+13.68%
6M Leistung:
+29.56%
1J Leistung:
+55.52%
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
DVA
Davita Inc
|
173.58 | 15.22B | 12.67B | 827.68M | 1.42B | 9.27 |
![]()
HCA
Hca Healthcare Inc
|
322.05 | 81.57B | 70.60B | 5.76B | 5.64B | 21.97 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
24.35 | 14.29B | 20.87B | 715.14M | 1.67B | 1.2209 |
![]()
THC
Tenet Healthcare Corp
|
140.47 | 13.72B | 20.97B | 3.13B | 2.39B | 31.21 |
![]()
UHS
Universal Health Services Inc
|
187.93 | 12.40B | 15.42B | 1.03B | 956.84M | 15.02 |
Davita Inc Stock (DVA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-03-06 | Eingeleitet | Barclays | Equal Weight |
2023-08-07 | Hochstufung | UBS | Neutral → Buy |
2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
2022-10-31 | Herabstufung | UBS | Buy → Neutral |
2022-08-19 | Fortgesetzt | UBS | Buy |
2022-06-21 | Bestätigt | BofA Securities | Underperform |
2021-09-10 | Eingeleitet | Cowen | Market Perform |
2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2019-01-08 | Hochstufung | UBS | Sell → Neutral |
2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
2018-12-14 | Eingeleitet | Barclays | Overweight |
2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2018-11-16 | Eingeleitet | UBS | Sell |
2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Empowered Funds LLC Buys 49,874 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
abrdn plc Decreases Stake in DaVita Inc. (NYSE:DVA) - MarketBeat
Strategic Financial Concepts LLC Acquires Shares of 62,661 DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita (DVA) Projected to Post Earnings on Tuesday - MarketBeat
DaVita stock soars to all-time high of $179 amid robust growth - MSN
Tobam Lowers Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita (DVA) to Release Earnings on Tuesday - MarketBeat
DaVita Inc. (NYSE:DVA) Short Interest Up 9.2% in January - MarketBeat
DaVita Inc. (NYSE:DVA) Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Tour DaVita's Net-Zero Dialysis Center -February 07, 2025 at 10:30 am EST - Marketscreener.com
Tour DaVita's Net-Zero Dialysis Center - 3BL Media
DaVita Inc. (NYSE:DVA) Shares Sold by GHP Investment Advisors Inc. - MarketBeat
DaVita (NYSE:DVA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Mediolanum International Funds Ltd Buys New Stake in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Celebrates Kidney Care Community Achievements in Year One of Largest-Ever Value-Based Care Program - Yahoo Finance
DaVita: Momentum Could Fade Given High Valuation - Seeking Alpha
Inlet Private Wealth LLC Sells 2,800 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
SteelPeak Wealth LLC Makes New $1.05 Million Investment in DaVita Inc. (NYSE:DVA) - MarketBeat
Forsta AP Fonden Has $3.01 Million Position in DaVita Inc. (NYSE:DVA) - MarketBeat
3 No-Brainer Warren Buffett Stocks to Buy Right Now - The Motley Fool
Patton Fund Management Inc. Reduces Position in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita (NYSE:DVA) Hits New 1-Year HighWhat's Next? - MarketBeat
DaVita (NYSE:DVA) jumps 3.5% this week, though earnings growth is still tracking behind five-year shareholder returns - Yahoo Finance
KBC Group NV Boosts Position in DaVita Inc. (NYSE:DVA) - MarketBeat
Is DaVita Inc. (DVA) Among Warren Buffett’s Longest-Held Stocks? - Insider Monkey
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Earnings Preview: What to Expect - MSN
Warren Buffett’s 10 Longest-Held Stocks - Insider Monkey
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call - The Malaysian Reserve
Does DaVita (NYSE:DVA) Have A Healthy Balance Sheet? - Simply Wall St
DaVita Inc. (DVA): Enhancing Kidney Care Through Advanced AI Models - Insider Monkey
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why - Yahoo Finance
DaVita stock soars to all-time high of $169.54 amid robust growth - MSN
Allen learns about dialysis legislation - Statesboro Herald
Bernstein Adjusts Price Target on DaVita to $184 From $161, Maintains Market Perform Rating - Marketscreener.com
Zacks Investment Ideas feature highlights: Nvidia, Vertiv, Vistra and DaVita - Yahoo Finance
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):